NDC product
TYPHIM VI
NDC 50090-1493 · A-S Medication Solutions
Key facts
| Product NDC | 50090-1493 |
|---|---|
| Proprietary name | TYPHIM VI |
| Nonproprietary name | SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN |
| Substances | SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN |
| Dosage form | INJECTION, SOLUTION |
| Route | INTRAMUSCULAR |
| Labeler | A-S Medication Solutions |
| Product type | VACCINE |
| Marketing category | BLA |
| Application number | BLA103936 |
| Pharmacologic classes | Actively Acquired Immunity [PE], Inactivated Salmonella Typhi Vaccine [EPC], Polysaccharides, Bacterial [CS], Vaccines, Inactivated [CS] and 1 more |
| Marketing start | Nov 28, 1994 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: